[Cytostatic therapy with Trenimon].
D000477:Alkylating Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D014228:Triaziquone / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D000477:Alkylating Agents; D014228:Triaziquone
Zytostatische Therapie mit Trenimon.